Combination of a nmda receptor antagonist and a...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/00 (2006.01) A61K 31/135 (2006.01) A61K 31/137 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2554959

The invention provides methods and compositions comprising a NMDA receptor antagonist once a monoamine oxidase (MAO) inhibitor GADPH inhibitor for the treatment dementia-related conditions, such as Parkinson~s disease and Alzheimer~s disease.

L'invention concerne des procédés et des compositions qui renferment un antagoniste de récepteur NMDA et un inhibiteur de monoamine oxydase (MAO) ou de GADPH pour le traitement d'affections liées à la démence, du type maladie de Parkinson et maladie d'Alzheimer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of a nmda receptor antagonist and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of a nmda receptor antagonist and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of a nmda receptor antagonist and a... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1650828

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.